Values CatLog read from this paper

Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates

PMID 9047311doi:10.1021/bi9617670Open in Browse

The paper itself is not on this site: read it at the publisher. This page lists only the values CatLog read from it.

CatLog read 76 records (228 values) from this paper: tissue-type plasminogen activator (tPA), tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA).

Read from the paper by an AI model and checked against the paper by a second, separate AI run; code converted the units. Values are in CatLog's units; each record opens in Browse with the line the paper prints and the checks.

EC 3.4.21.68

Records read from this paper
EnzymeOrganismSubstratekcat (s⁻¹)Km (mM)kcat/Km (mM⁻¹ s⁻¹)ConditionsOpen record
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl1.470.393.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0570.0411.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.310.0983.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0890.0691.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0210.00742.9pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0740.0362.1pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0440.0162.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0820.0581.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.710.116.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.040.970.04pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.080.460.18pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0970.0156.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.540.0668.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.530.361.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.10.033.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.150.0473.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.490.0915.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.340.142.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.250.0269.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl1.030.07114.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0110.0470.24pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA)—tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0840.10.83pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.370.01132.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0340.0113pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.170.01214.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.10.0176.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0180.011.9pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)0.140.121.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)0.220.0962.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)0.660.144.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)0.150.0295.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)0.540.02521.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.510.0776.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)0.320.0883.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)0.20.0742.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)0.470.0489.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)3.60.09537.9pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)0.940.08411.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0250.00783.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.190.0335.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.160.008120.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.040.00854.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.20.008823.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0970.0137.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0470.0133.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0170.00266.4pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.150.0324.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.180.01412.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.250.01516.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.440.006666.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0990.0263.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.00840.0110.71pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0610.041.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0190.0141.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)0.090.320.28pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)0.130.250.52pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)0.270.181.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)0.0830.0631.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)0.450.0637.1pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0160.00572.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)0.150.151pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)0.290.330.88pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)0.330.122.8pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)1.10.09911.1pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)0.250.0793.2pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0110.00731.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0210.0220.95pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0590.0252.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)0.0120.0230.51pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0380.0152.5pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.0220.021.1pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)0.010.0170.6pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.0190.0121.7pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0360.0191.9pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)0.0650.0292.3pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated)
tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA)—tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl0.110.0167.1pH 7.4, 25 °COpen record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl